Category: Research

Researchers from the John Curtin School of Medical Research in Canberra, Australia have discovered that the insulin-producing beta cells need a complex sugar, heparan sulfate, for their survival and without it they die. Replacement of heparan sulfate in the beta cells rescues the cells from dying in culture and protects them from oxidative damage...

Novartis has decided to terminate the ALTITUDE study evaluating the potential benefits of Rasilez/Tekturna (aliskiren) in reduction of risk of cardiovascular and renal events in patients with type 2 diabetes and renal impairment...

JDRF announced it will support a pioneering diabetes research program that is developing a first-of-its-kind cell therapy for type 1 diabetes and other forms of insulin-dependent diabetes. The therapy is a combination product that packages immature cells made from human embryonic stem cells (hESCs) that over time develop into mature pancreatic hormone producing cells...

Researchers at Joslin Diabetes Center have determined key differences between Type 1 and Type 2 diabetes in the Asian American population. This study, published today in PLoS ONE, identified ways to differentiate the types of diabetes, which can be clinically similar in young Asian Americans.

The Juvenile Diabetes Research Foundation (JDRF) and The Leona M. and Harry B. Helmsley Charitable Trust, two of the largest non-government funders of type 1 diabetes programs, announced that they have formalized a collaboration that will foster a new level of cooperation between the organizations. The goal of the collaboration...

A new study from VTT Technical Research Centre of Finland has found that type 1 diabetes, or autoimmune diabetes, is preceded by diminished gut microbial diversity of the Clostridium leptum subgroup, elevated plasma leptin and enhanced glucose-stimulated insulin secretion. In the past, VTT researches have found that specific metabolic disturbances...